Neuroinflammatory chemokine networks in transgenic models of Alzheimer’s disease: A comparative multi-compartmental analysis
Human & Experimental Toxicology · 2025
DOI: 10.1177/09603271251348723 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Human & Experimental Toxicology, 2025. Verfasst von Yangyan Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Gannan Medical University, Ganzhou, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Chemokines, Neuroinflammatory Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer’s disease (AD) progression is critically modulated by neuroinflammatory cascades involving chemokine-mediated glial activation.
Objective
This study aimed to systematically compare compartment-specific chemokine signatures between two distinct AD mouse models (2×Tg-AD [APPswe/PS1dE9] and 3×Tg-AD [APPswe/PS1M146V/TauP301L]), hypothesizing that differential chemokine expression patterns would emerge in a model- and brain region-specific manner, correlating with glial activation profiles.
Results
Using a Luminex liquid suspension chip assay, we quantified 22 chemokines in serum and brain tissues from transgenic and non-transgenic controls, complemented by Western blot analysis of microglial and astrocytic markers. Twenty-two chemokines were quantitatively analyzed with three key findings: First, serum analysis revealed elevated levels of (i) CCL11, CCL17, CCL24, CCL27, and CXCL12 in 3×Tg-AD versus non-Tg mice; (ii) CCL22 in 2×Tg-AD versus non-Tg mice; and (iii) CCL5, CCL11, CCL17, CCL24, CCL27, and CXCL12 in 3×Tg-AD versus 2×Tg-AD mice. Second, hippocampal changes showed upregulation of CCL3/CCL12 in 2×Tg-AD and CXCL16 in 3×Tg-AD mice, with cortical alterations demonstrating distinct CCL3/CCL12/CCL4 increases in 2×Tg-AD versus elevated CCL1/CXCL13 in 3×Tg-AD mice. Third, Western blot confirmed enhanced hippocampal microglial activation specifically in 3×Tg-AD mice.
Conclusion
Our findings establish model-specific chemokine signatures that differentially engage neuroinflammatory pathways, suggesting that 3×Tg-AD mice may better replicate human AD’s complex chemokine-glia interactions. This compartmentalized profiling provides a framework for targeting chemokine networks in model-specific therapeutic development and biomarker discovery. Further studies are needed to determine whether elevated chemokine expression directly contributes to microglial activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medicine, Gannan Medical University, Ganzhou, China.
ORCID-Profile: Futao Zhou
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Sun, Y., Xie, X., Zou, X., & Zhou, F. (2025). Neuroinflammatory chemokine networks in transgenic models of Alzheimer’s disease: A comparative multi-compartmental analysis. Human & Experimental Toxicology. https://doi.org/10.1177/09603271251348723
Vancouver
Sun Y, Xie X, Zou X, Zhou F. Neuroinflammatory chemokine networks in transgenic models of Alzheimer’s disease: A comparative multi-compartmental analysis. Human & Experimental Toxicology. 2025. doi:10.1177/09603271251348723
BibTeX
@article{Sun2025,
author = {Sun, Yangyan and Xie, Xinhua and Zou, Xiaoqin and Zhou, Futao},
title = {Neuroinflammatory chemokine networks in transgenic models of Alzheimer’s disease: A comparative multi-compartmental analysis},
journal = {Human & Experimental Toxicology},
year = {2025},
doi = {10.1177/09603271251348723}
}
EUVIMED